Micron Technology Inc. faces a heightened bar that the company itself raised heading for the rest of the year as widespread chip shortages are helping push up prices for its core memory chips.
There’s no legal precedent to know how courts will view an institution’s response to a student or employee refusing a COVID-19 vaccine under emergency-use status.
Losses that triggered the liquidation of positions approaching $30 billion in value bring to light complicated financial instruments used by European investors that are effectively banned in the U.S. but could still have spillover effects domesticall...